Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

about

Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.

P2860

Q47683031-ED1D1B61-4335-4570-9FB3-D5D6A379C135

P2860

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

Item

http://www.wikidata.org/entity/Q39164012

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

@en

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

@nl

type

Item

label

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

@en

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

@nl

prefLabel

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

@en

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

@nl

P1476

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

@en

P2093

Ajenthen Ranjan

http://www.w3.org/2001/XMLSchema#string

Isabelle Steineck

http://www.w3.org/2001/XMLSchema#string

Signe Schmidt

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus

Progress of artificial pancreas devices towards clinical use: the first outpatient studies

Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic eva

A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes.

Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.

Effects of advanced carbohydrate counting in patients with type 1 diabetes: a systematic review.

Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk

Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase.

Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump.

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis

P304

50-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1932296816672689

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kirsten Nørgaard

P577

2016-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28264173

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

hypoglycemia

P932

5375081

http://www.w3.org/2001/XMLSchema#string

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

about

P2860

P2860

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932